ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Clinical trials for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for MG patients: study tests safer drug combos
Disease control Recruiting nowThis study is testing how safe and effective different drug combinations are for people with myasthenia gravis, a condition that causes muscle weakness. Researchers want to find treatments that reduce side effects and improve quality of life. About 70 adults with generalized MG a…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug combo aims to ease severe muscle weakness in MG patients
Disease control Recruiting nowThis study tests whether adding empasiprubart to the standard treatment efgartigimod can further improve symptoms in people with generalized myasthenia gravis (gMG) who still have muscle weakness. About 70 adults with a specific antibody type (AChR-Ab positive) will receive the c…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:53 UTC